DK0655244T5 - Sammensætning på basis af aminosyrer til behandling af infektioner - Google Patents
Sammensætning på basis af aminosyrer til behandling af infektionerInfo
- Publication number
- DK0655244T5 DK0655244T5 DK94402420T DK94402420T DK0655244T5 DK 0655244 T5 DK0655244 T5 DK 0655244T5 DK 94402420 T DK94402420 T DK 94402420T DK 94402420 T DK94402420 T DK 94402420T DK 0655244 T5 DK0655244 T5 DK 0655244T5
- Authority
- DK
- Denmark
- Prior art keywords
- cysteine
- amino acids
- proportion
- composition based
- treat infections
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 150000001413 amino acids Chemical class 0.000 title abstract 3
- 208000015181 infectious disease Diseases 0.000 title 1
- 235000018417 cysteine Nutrition 0.000 abstract 4
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 abstract 4
- 235000001014 amino acid Nutrition 0.000 abstract 2
- 108010009736 Protein Hydrolysates Proteins 0.000 abstract 1
- 235000016709 nutrition Nutrition 0.000 abstract 1
- 238000007911 parenteral administration Methods 0.000 abstract 1
- 239000002243 precursor Substances 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 229940002612 prodrug Drugs 0.000 abstract 1
- 239000000651 prodrug Substances 0.000 abstract 1
- 235000018102 proteins Nutrition 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9312884A FR2711529B1 (fr) | 1993-10-28 | 1993-10-28 | Composition à base d'acides aminés destinée au traitement d'une infection ou d'une agression engendrant une réaction inflammatoire, chez les animaux et chez l'homme. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DK0655244T3 DK0655244T3 (da) | 2002-08-05 |
| DK0655244T5 true DK0655244T5 (da) | 2008-10-13 |
Family
ID=9452315
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK94402420T DK0655244T5 (da) | 1993-10-28 | 1994-10-27 | Sammensætning på basis af aminosyrer til behandling af infektioner |
Country Status (9)
| Country | Link |
|---|---|
| EP (1) | EP0655244B2 (es) |
| KR (1) | KR950010884A (es) |
| AT (1) | ATE216234T1 (es) |
| CA (1) | CA2134380C (es) |
| DE (1) | DE69430416T3 (es) |
| DK (1) | DK0655244T5 (es) |
| ES (1) | ES2171439T5 (es) |
| FR (1) | FR2711529B1 (es) |
| PT (1) | PT655244E (es) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1999038507A1 (en) * | 1998-01-30 | 1999-08-05 | David George Le Couteur | Reversal and prevention of clinically significant aspects of aging through oral use of hepatic artery vasodilator and other agents which increase hepatic oxygenation |
| SK11212002A3 (sk) * | 2000-02-04 | 2003-01-09 | Soci�T� Des Produits Nestl� S.A. | Použitie proteínového zdroja, spôsob zachovania syntézy mucínov v tele pacienta a výživový prípravok |
| EP1302115A1 (fr) * | 2001-10-16 | 2003-04-16 | Societe Des Produits Nestle S.A. | Utilisation de cystathionine |
| JP2007522208A (ja) * | 2004-02-12 | 2007-08-09 | キャンピナ・ネダーランド・ホールディング・ビー．ブイ． | チオールのホメオスタシスを改良するためのシステインリッチのペプチド |
| EP1890688A2 (en) * | 2005-06-14 | 2008-02-27 | Nestec S.A. | Nutritional method |
| DE102006018293A1 (de) * | 2006-04-20 | 2007-10-25 | Fresenius Kabi Deutschland Gmbh | Pädiatrische Aminosäurelösung zur parenteralen Ernäherung |
| EP2165713B1 (en) | 2008-09-19 | 2012-11-14 | Nestec S.A. | Whey and thymus function |
| WO2011021926A1 (en) | 2009-08-21 | 2011-02-24 | N.V. Nutricia | Regulating the amino acid pool used for the acute-phase protein synthesis |
| EP2444083A1 (en) | 2010-10-21 | 2012-04-25 | Nestec S.A. | Cysteine and food intake |
| WO2024122796A1 (ko) * | 2022-12-05 | 2024-06-13 | 의료법인 성광의료재단 | 아스파르트산을 유효성분으로 포함하는 패혈증의 예방 또는 치료용 약학적 조성물 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2531204A1 (de) * | 1975-07-12 | 1977-01-13 | Fresenius Chem Pharm Ind | L-aminosaeuregemische fuer parenterale oder orale anwendung |
| DE2946563A1 (de) * | 1979-11-17 | 1981-05-21 | B. Braun Melsungen Ag, 3508 Melsungen | Aminosaeureloesung zur parenteralen infusion |
| DE3026368A1 (de) * | 1980-07-11 | 1982-02-18 | Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München | Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion |
| US4604286A (en) * | 1984-09-17 | 1986-08-05 | Daigo Nutritive Chemicals, Ltd. | Infusion solution for parenteral nutrition |
| EP0264953B1 (de) * | 1986-10-24 | 1991-05-08 | PFRIMMER KABI GMBH & CO. KG | Verwendung von N, N'-bis-L-Aminosäure-L-cystinpeptiden in Aminosäure-Präparaten für orale und parenterale Ernährung |
| SE8704217D0 (sv) * | 1987-10-29 | 1987-10-29 | Vinnars Erik Ab | Aminosyrakomposition for parenteral neringstillforsel |
| US5224409A (en) † | 1991-03-19 | 1993-07-06 | Ashlock Company | Apparatus for producing helical slices |
| US5214062A (en) † | 1992-04-08 | 1993-05-25 | Clintec Nutrition Co. | Method and composition for treating immune disorders, inflammation and chronic infections |
| AU6060694A (en) † | 1993-05-10 | 1994-11-17 | Transcend Therapeutics, Inc | Method for treating acquired immune deficiency syndrome |
-
1993
- 1993-10-28 FR FR9312884A patent/FR2711529B1/fr not_active Expired - Lifetime
-
1994
- 1994-10-26 CA CA2134380A patent/CA2134380C/en not_active Expired - Lifetime
- 1994-10-27 ES ES94402420T patent/ES2171439T5/es not_active Expired - Lifetime
- 1994-10-27 AT AT94402420T patent/ATE216234T1/de not_active IP Right Cessation
- 1994-10-27 DE DE69430416T patent/DE69430416T3/de not_active Expired - Lifetime
- 1994-10-27 DK DK94402420T patent/DK0655244T5/da active
- 1994-10-27 PT PT94402420T patent/PT655244E/pt unknown
- 1994-10-27 EP EP94402420A patent/EP0655244B2/fr not_active Expired - Lifetime
- 1994-10-28 KR KR1019940027823A patent/KR950010884A/ko not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PT655244E (pt) | 2002-08-30 |
| CA2134380A1 (en) | 1995-04-29 |
| ES2171439T5 (es) | 2008-12-01 |
| FR2711529B1 (fr) | 1996-07-05 |
| DE69430416T3 (de) | 2009-01-22 |
| DE69430416T2 (de) | 2002-12-05 |
| ES2171439T3 (es) | 2002-09-16 |
| DK0655244T3 (da) | 2002-08-05 |
| EP0655244B2 (fr) | 2008-06-11 |
| ATE216234T1 (de) | 2002-05-15 |
| FR2711529A1 (fr) | 1995-05-05 |
| DE69430416D1 (de) | 2002-05-23 |
| EP0655244A1 (fr) | 1995-05-31 |
| CA2134380C (en) | 2010-06-22 |
| KR950010884A (ko) | 1995-05-15 |
| EP0655244B1 (fr) | 2002-04-17 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2016950T3 (da) | Farmaceutisk sammensætning omfattende et exendin-4-peptid | |
| DE69839812D1 (de) | Analoge des menschlichen interferon-alpha mit niedriger toxizität | |
| GEP20074123B (en) | Amino acids with affinity for the alpha−2−delta−protein | |
| PE20000560A1 (es) | Uso de peg-ifn-alfa y ribavirina para el tratamiento de hepatitis c cronica | |
| ES2141229T3 (es) | Productos farmaceuticos de proteinas y peptidos modificados. | |
| RS20090086A (en) | Nucleoside analogs with carobxamidine modified monocyclic base | |
| DE59810596D1 (de) | Humanes, rekombinantes interferon-beta mit verbesserter löslichkeit | |
| DK0655244T3 (da) | Sammensætning på basis af aminosyrer til behandling af infektioner | |
| GEP20063763B (en) | Thrombopoietin Receptor Modulating Peptide | |
| ATE62407T1 (de) | Geschmack abdeckende zusammensetzungen. | |
| ATE69164T1 (de) | Arzneimittel zur behandlung von uraemie. | |
| MY124560A (en) | Amino acid compositions and use thereof in immunosuppression | |
| BG97123A (bg) | Производни на човешка, стимулирана от жлъчните соли, липаза и фармацевтични състави на тяхна основа | |
| ES2087337T3 (es) | Composiciones de implantes que contienen una proteina, peptido o polipeptido biologicamente activos. | |
| ATE233105T1 (de) | Pharmazeutische zubereitung für die intravenöse oder intramuskuläre verabreichung von octreotid | |
| UY24780A1 (es) | Composiciones farmacéuticas estabilizadas a base de quinupristina y dalfopristina y su preparación. | |
| FI942938A0 (fi) | Soijaproteiini tai -hydrolysaatit farmaseuttisissa koostumuksissa bioaktiivisten peptidien suojana entsymaattista inaktivoitumista vastaan | |
| EP1557466A4 (en) | TUMOR ANTIGEN PROTEIN AND USE THEREOF | |
| AU3693097A (en) | Derivatives of somatostatin, amino acids or oligopeptides and their combination useful for promoting body growth | |
| FR2710244B3 (fr) | Composition diététique à base d'acides aminés essentiels. | |
| SE9100284D0 (sv) | Novel peptide | |
| IT1247493B (it) | Sali ad attivita' antiinfiammatoria, analgesica e antipiretica e composizioni farmaceutiche che li contengono | |
| ITMI931822A1 (it) | Composizioni farmaceutiche a base di nimesulide, somministrabili per via orale, non gastrolesive e/o a rilascio controllato | |
| SE8700125L (sv) | Korta peptider vid behandling av psoriasis och schizofreni |